Document Detail

Therapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence.
MedLine Citation:
PMID:  24575173     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Heart failure with preserved ejection fraction (HFPEF) is common and represents a major challenge in cardiovascular medicine. Most of the current treatment of HFPEF is based on morbidity benefits and symptom reduction. Various pharmacological interventions available for heart failure with reduced ejection fraction have not been supported by clinical studies for HFPEF. Addressing the specific aetiology and aggressive risk factor modification remain the mainstay in the treatment of HFPEF. We present a brief overview of the currently recommended therapeutic options with available evidence.
Muhammad Asrar ul Haq; Chiew Wong; Vivek Mutha; Nagesh Anavekar; Kwang Lim; Peter Barlis; David L Hare
Related Documents :
18422663 - Gender-dependent differences in echocardiographic characteristics of murine hearts.
11213303 - Doppler hemodynamics of 51 clinically and echocardiographically normal pulmonary valve ...
1735793 - Catheter ablation of hemodynamically compromising incessant atrioventricular tachycardia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  World journal of cardiology     Volume:  6     ISSN:  1949-8462     ISO Abbreviation:  World J Cardiol     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2014-02-27     Completed Date:  2014-06-24     Revised Date:  2014-08-14    
Medline Journal Info:
Nlm Unique ID:  101537090     Medline TA:  World J Cardiol     Country:  China    
Other Details:
Languages:  eng     Pagination:  67-76     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The role of nutrition and nutraceutical supplements in the treatment of hypertension.
Next Document:  Infiltrative cardiac lymphoma with tricuspid valve involvement in a young man.